Hutch News
WT1 T-cell Receptor Transduced T cells prevent AML relapse
From the Chapuis and Greenberg Labs, Clinical Research Division
Leukemia researcher Dr. Jerry Radich receives Kurt Enslein Endowed Chair
New chair continues legacy of giving sparked by lifesaving care
From Omaha to a Seattle lab, with 2 side trips to hell
Childhood AML survivor interns with the scientist who sequenced her genome
Immunotherapy prevents relapse in small leukemia trial
Engineered T cells kept leukemia from returning in 12 high-risk patients
The response is what counts
From the Othus Group, Public Health Sciences Division
5 questions with a cancer immunotherapy expert
Dr. Phil Greenberg to receive high honor for his contributions to the field
Hyundai Hope on Wheels presents Fred Hutch scientist with grant for childhood leukemia research
$300K Scholar Hope Grant will support Dr. Roland Walter’s research on acute myeloid leukemia
Acclaimed oncologist, author, Dr. Siddhartha Mukherjee visits Fred Hutch
'If you are not preventing, curing and treating cancer, you are off target. You have not achieved the mandate.'
Immunotherapy strategy for ovarian cancer aims to rewire a ‘kill switch’ to ramp-up signal
T cells bearing a new engineered protein boost immunotherapy’s effectiveness in laboratory models of AML, ovarian, pancreatic cancers
How does leukemia escape from immunotherapy?
New tech enables deep dive into mysterious results, sets stage for future improvements
Big data in cancer research
New study in childhood leukemia illustrates challenges and power of cutting-edge genomic technologies’ huge data sets
‘Remarkable’ distinctions in pediatric leukemia point toward improved treatment
Big new study in pediatric and young adult acute myeloid leukemia warns against ‘trickle-down therapeutics’
Good News: Hutch investigators develop, validate novel risk-assessment model for acute myeloid leukemia
Celebrating faculty and staff achievements
Good News: Kleberg Foundation grant to support clinical trial for leukemia patients
Celebrating faculty and staff achievements
Bringing a leukemia treatment back to life with precision medicine
New research writes latest chapter in one drug's story
30 years after a bone marrow transplant, a cancer survivor looks back
30 years after an early BMT, a cancer survivor pays it forward by helping researchers ‘make it better for others’
Capturing information from thousands of cells at once
New technology allows scientists to peek inside nearly 70,000 cells in single experiment
What's new in blood diseases
Four things to watch from the 2016 annual meeting of the American Society of Hematology
.jpg)
The quest to better understand the deadliest childhood leukemia
Oncologists are beginning to leverage unique genomic characteristics of pediatric AML to improve treatment and prognosis
'Kids are not little adults'
Why children with cancer need their own drugs and their own research
Cost of survival: Coping with treatment complications beyond the cure
Treatment complications can impact lives for years after cure but some cancers survivors are reluctant to reveal their pain
Why some patients keep their cancer secret — and how oncologists guide them through that chosen seclusion
Why some patients don’t divulge their diagnoses — and how oncologists guide them through their chosen seclusion
Good News: Hsieh PCF Award; Biernacki hematology training program; Soh Damon Runyon Award
Celebrating faculty and staff achievements
Good News: first Hutch United fellowships awarded; Dr. Soheil Meshinchi receives $500K AML grant
Celebrating faculty and staff achievements